Transforming growth factor-β1 hyperexpression in African American end- stage renal disease patients. Rapid communication

Kidney International

Volumn 53, Issue 3, 1998, Pages 639-644

  Suthanthiran, Manikkam ^a   Khanna, Ashwani ^b   Cukran, David ^b   Adhikarla, Rohini ^b   Sharma, Vijay K ^b   Singh, Tejinder ^b   August, Phyllis ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

African American ESRD; End stage renal disease; Genetics and TGF 1; HIV and genetics; Hypertension; Race and ESRD; Renal failure in blacks; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEGRO; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

EID: 0031893923     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00858.x     Document Type: Article

References (46)

1. UNITED STATES RENAL DATA SYSTEM (USRDS): USRDS 1996 Annual Data Report. Bethesda, National Institutes of Health, NIDDK, 1996
2. KLAG MJ, WHELTON PK, RANDALL BL, NEATON JD, BRANCATI FL, STAMLER J: End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 277:1293-1298, 1997
3. KLAHR S: Prevention of progression of nephropathy. Nephrol Dial Transplant 12(Suppl 2):63-66, 1997
4. BORDER WA, NOBEL NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
5. KURIHARA H, YOSHIZUMI M, SUGIYAMA T, TAKAKU F, YANAGISAWA M, MASAKI T, HAMAOKI M, KATO H, YAZAKI Y: Transforming growth factor β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 159:1435-1440, 1989
6. VAN SNICK J: Interleukin-6: An overview. Annu Rev Immunol 8:253-278, 1990
7. TRACEY KJ, CERAMI A: Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491-503, 1994
8. DESCAMPS-LATSCHA B, HERBELIN A: Long-term dialysis and cellular immunity: A critical survey. Kidney Int 43(Suppl 41):S135-S142, 1993
9. KHANNA A, LI B, STENZEL KH, SUTHANTHIRAN M: Regulation of new DNA synthesis in mammalian cells by cyclosporine: Demonstration of a transforming growth factor β dependent mechanism of inhibition of cell growth. Transplantation 57:577-582, 1994
10. SAS INSTITUTE INC: SAS User's Guide: Statistics (Version 5). Cary, SAS Institute, 1985, 956 pp
11. PARKER T: Hemodialysis adequacy, in Principles and Practice of Dialysis, edited by HENRICH WL, Baltimore, Williams & Wilkins, 1994, pp. 63-75
12. HAKIM RM: Choice of the hemodialysis membrane, in Principles and Practice of Dialysis, edited by HENRICH WL, Baltimore, Williams & Wilkins, 1994, pp 1-7
13. GIRNDT M, KÖHLER H, SCHIEDHELM-WEICK E, SHLAAK JF, MEYER ZUM BÜSCHENFELDE K-H, FLEISCHER B: Production of interleukin-6, tumor necrosis factor-α and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 47:559-565, 1995
14. ISAKA Y, FUJIWARA Y, UEDA N, KANEDA Y, KAMADAT, IMAI E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
15. AKAGI Y, ISAKAY, ARAI M, KANEKIT, TAKENAKA M, MORIYAMAT, KANEDA Y, ANDO A, ORITAY, KAMADA T, UEDA N, IMAI E: Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155, 1996
16. BÖTTINGER EP, LETTERIO JJ, ROBERTS AB: Biology of TGF-β in knockout and transgenic mouse models. Kidney Int 51:1255-1360, 1997
17. YAMAMOTO T, NOBLE NA, COHEN AH, NAST CC, HISHIDA A, GOLD LI, BORDER WA: Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
18. IWANO M, KUBO A, NISHINO T, SATO H, NISHIOKA H, AKAI Y, KURIOKA H, FUJII Y, KANAUCHI M, SHIIKI H, DOHI K: Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int 49:1120-1126, 1996
19. 1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 49:1297-1303, 1996
20. ERGUL S, PARISH DC, PUETT D, ERGUL A: Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension. Hypertension 28:652-655, 1996
21. LOTZ M, SETH P: TGB-beta and HIV infection. Ann NY Acad Sci 685:501-511, 1993
22. LACKLAND DT, KEIL JE: Epidemiology of hypertension in African-Americans. Semin Nephrol 16:63-70, 1996
23. GRIM CE, ROBINSON M: Blood pressure variation in blacks: Genetic factors. Semin Nephrol 16:83-93, 1996
24. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
25. BATTISTINI B, CHAILLER P, D'ORLEANS-JUSTE P, BRIERE N, SIROIS P: Growth regulatory properties of endothelins. Peptides 14:385-399, 1993
26. SALTIS J, AGROTIS A, BOBIL A: Regulation and interactions of transforming growth factor-beta with cardiovascular cells: Implications for development and disease. Clin Exp Pharmacol Physiol 23:193-200, 1996
27. NABEL EG, SHUM L, POMPILI VJ, YANG ZY, SAN H, SHU HB, LIPTAY S, GOLD L, GORDON D, DERYNCK R, NABEL GJ: Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 90:10759-10763, 1993
28. ROSTAND SG, BROWN G, KIRK KA, RUTSKY EA, DUSTAN HP: Renal insufficiency in treated essential hypertension. N Engl J Med 320:684-688, 1989
29. PERRY HM JR, MILLER JP, FORNOFF JR, BATY JD, SAMBHI MP, RUTAN G, MOSKOWITZ DW, CARMODY SE: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25:587-594, 1995
30. TAMAKI K, OKUDA S, NAKAYAMA M, YANAGIDA T, FUJISHIMA M: Transforming growth factor-beta 1 in hypertensive renal injury in Dahl salt-sensitive rats. J Am Soc Nephrol 7:2578-2589, 1996
31. WEINBERGER MH: Hypertension in African Americans: The role of sodium chloride and extracellular fluid volume. Semin Nephrol 16: 110-116, 1996
32. BERGMAN SM, CURTIS JJ: Possible mediators in hypertension: Renal factors. Semin Nephrol 16:134-139, 1996
33. TRACY RE: Renovasculopathies of hypertension and the rise of blood pressure with age in blacks and whites. Semin Nephrol 16:126-133, 1996
34. GRAINGER DJ, KEMP PR, METCALFE JC, LIU AC, LAWN RM, WILLIAMS NR, GRACE AA, SCHOFIELD PM, CHAUHAN A: The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclorisis. Nature Med 1:74-79, 1995
35. ROSTAND SG, KIRK KA, RUTSKY EA: Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 22:304-308, 1982
36. KEIL JE, SUTHERLAND SE, HAMES CG, LACKLAND DT, GAZES PC, KNAPP RG, TYROLER HA: Coronary disease mortality and risk factors in Black and White men. Arch Intern Med 155:1521-1527, 1995
37. PENISTON RL, ADAMS-CAMPBELL L, FLETCHER JW, WILLIAMS EC, MURIGANDE C, MENSAH E, CRITTENDEN MD DIGGS JA: Coronary arteriographic findings in black patients and risk markers for coronary artery disease. Am Heart J 127:552-559, 1994
38. OOI WL, BUDNER NS, COHEN H, MADHAVAN S, ALDERMAN MH: Impact of race on treatment response and cardiovascular disease among hypertensives. Hypertension 14:227-234, 1989
39. WILSON AG, SYMONS JA, MCDOWELL TL, MCDEVITT HO, DUFF GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199, 1997
40. TURNER DM, WILLIAMS DM, SANKARAN D, LAZARUS M, SINNOTT PJ, HUTCHINSON IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8, 1997
41. WESTENDORP RGJ, LANGERMANS JAM, HUIZINGATWJ, ELOUALI AH, VERWEH CL, BOOMSMA DI, VANDENBROUKE JP: Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170-173, 1997
42. CAMBIEN F, RICARD S, TROESCH A, MALLET C, GÉNÉRÉNAZ L, EVANS A, ARVEILER D, LUC G, RUIDAVETS J-B, POIRIER O: Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28:881-887, 1996
43. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
44. ISHIDOYA S, MORRISSEY J, MCCRACKEN R, REYES A, KLAHR S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294, 1995
45. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
46. MASCHIO G, ALBERTI D, JANIN G, LOCATELLI F, MANN JFE, MOTOLESE M, PONTICELLI C, RITZ E, ZUCCHELLI P: Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996